Literature DB >> 9333056

mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

A Tait-Kamradt1, J Clancy, M Cronan, F Dib-Hajj, L Wondrack, W Yuan, J Sutcliffe.   

Abstract

Recently, it was shown that a significant number of erythromycin-resistant Streptococcus pneumoniae and Streptococcus pyogenes strains contain a determinant that mediates resistance via a putative efflux pump. The gene encoding the erythromycin-resistant determinant was cloned and sequenced from three strains of S. pneumoniae bearing the M phenotype (macrolide resistant but clindamycin and streptogramin B susceptible). The DNA sequences of mefE were nearly identical, with only 2-nucleotide differences between genes from any two strains. When the mefE sequences were compared to the mefA sequence from S. pyogenes, the two genes were found to be closely related (90% identity). Strains of S. pneumoniae were constructed to confirm that mefE is necessary to confer erythromycin resistance and to explore the substrate specificity of the pump; no substrates other than 14- and 15-membered macrolides were identified.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333056      PMCID: PMC164101     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family.

Authors:  J I Ross; E A Eady; J H Cove; W J Cunliffe; S Baumberg; J C Wootton
Journal:  Mol Microbiol       Date:  1990-07       Impact factor: 3.501

2.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

Review 3.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Erythromycin-resistant Streptococcus pyogenes.

Authors:  G Phillips; D Parratt; G V Orange; I Harper; H McEwan; N Young
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

5.  Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545.

Authors:  P Trieu-Cuot; C Poyart-Salmeron; C Carlier; P Courvalin
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

6.  Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis.

Authors:  J I Ross; A M Farrell; E A Eady; J H Cove; W J Cunliffe
Journal:  J Antimicrob Chemother       Date:  1989-12       Impact factor: 5.790

7.  Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides.

Authors:  G M Bright; A A Nagel; J Bordner; K A Desai; J N Dibrino; J Nowakowska; L Vincent; R M Watrous; F C Sciavolino; A R English
Journal:  J Antibiot (Tokyo)       Date:  1988-08       Impact factor: 2.649

8.  A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin.

Authors:  R J Scott; J Naidoo; N F Lightfoot; R C George
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

9.  Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin.

Authors:  M Arthur; A Andremont; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia.

Authors:  N Stingemore; G R Francis; M Toohey; D B McGechie
Journal:  Med J Aust       Date:  1989-06-05       Impact factor: 7.738

View more
  100 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Incidence of mefA and mefE genes in viridans group streptococci.

Authors:  C Arpin; M H Canron; J Maugein; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.

Authors:  F Depardieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.

Authors:  M P Montanari; M Mingoia; E Giovanetti; P E Varaldo
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa.

Authors:  L McGee; K P Klugman; A Wasas; T Capper; A Brink
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

7.  Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes.

Authors:  T Ono; S Shiota; K Hirota; K Nemoto; T Tsuchiya; Y Miyake
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.

Authors:  R R Reinert; S Simic; A Al-Lahham; S Reinert; M Lemperle; R Lütticken
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

9.  Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.

Authors:  J A Jacobs; G J van Baar; N H London; J H Tjhie; L M Schouls; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

10.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.